Medical staff in Western Australia have been warned after reports of the wrong immunisations being given to patients.

An urgent warning has been issued by one Aussie health authority after medical staff reportedly gave the wrong RSV ...

The WA Department of Health has sent an urgent reminder to medical staff to make sure they’re giving patients the right RSV ...

Dr Reddy’s Laboratories prepares for US market challenges with strategic growth initiatives and strong financial performance in FY25.

A newly configured federal vaccine panel's June 25 action is expected to improve options to protect infants from potentially deadly RSV.

The eight new ACIP members met for the first time June 25 after Kennedy fired all 17 original members of the committee June 9 ...

The U.S. Centers for Disease Control and Prevention's revamped vaccine advisory panel on Wednesday postponed its vote on the use of respiratory syncytial virus therapies to Thursday. The panel, which ...

Sanofi’s SNY stock has been trading below its 200-day and 50-day moving averages since early June. On June 23, the stock’s closing price of $48.18 was below its 50-day moving average of $50.32 and the ...

Sanofi is shipping Beyfortus (nirsevimab) starting in early Q3 to ensure broad availability well ahead of the 2025-2026 respiratory syncytial virus (RSV) season, which typically starts in November and ...

The U.S. Food and Drug Administration on Monday approved Merck's preventive antibody shot to protect infants up to one year of age from respiratory syncytial virus during their first RSV season, the ...

Sanofi accelerates global shipping of Beyfortus to prepare healthcare providers months ahead of 2025-2026 RSV season Paris, June 9, 2025.

Sanofi said Beyfortus duration of protection was extended for six months in the EU. This year’s EU shipments are marked by an important change to the Beyfortus EU label, extending the duration ...